Yasmin Schmid
Senior Attending Physician at University Hospital Basel
Key Impact
Clinical pharmacologist specializing in the safety and dose-response profiles of LSD and MDMA.
Background & Research
Dr. Yasmin Schmid is a leading expert in the clinical pharmacology of serotonergic psychedelics. Her research at the University of Basel characterizes the acute and long-lasting effects of LSD and MDMA in both healthy volunteers and patients. She focus on the safety, efficacy, and neurobiological mechanisms that underpin the therapeutic potential of these substances in palliative care and psychiatry.
Collaboration Network
32 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Healthy VolunteersAnxiety DisordersMedicinal Chemistry & Drug DevelopmentDepressive DisordersInterpersonal Functioning & Social ConnectednessPersonality & Trait FactorsPTSDMajor Depressive Disorder (MDD)Neuroimaging & Brain MeasuresSubstance Use Disorders (SUD)Palliative & End-of-Life DistressOlder AdultsSet & SettingPublic Health, Prevention & Behaviour ChangeHeadache Disorders (Cluster & Migraine)Chronic PainSchizophreniaObsessive-Compulsive Disorder (OCD)AdolescentsTobacco/Nicotine Use Disorder (TUD)Equity and EthicsMicrodosingSafety & Risk Management